Global Peripheral Artery Disease Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 6.8% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jun 6, 2018--The “Peripheral Artery Disease Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering.
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a CAGR of 6.8% during the study period.
The growth in geriatric population coupled with increase in incidence of peripheral artery disease are the major factors that drive the growth of the peripheral artery disease market. In addition, introduction of advanced interventional products such as drug coated balloons also boost the market growth. However, restenosis majorly restraints the market growth.
The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories.
Key Market Players:Abbott Laboratories Boston Scientific Corporation Cook Medical Cardinal Health, Inc. C. R. Bard, Inc. Medtronic plc Terumo Corporation The Spectranetics Corporation AngioDynamics, Inc. BIOTRONIK B. Braun Melsungen AG
Key Topics Covered:
2. Executive Summary
3. Market Overview
4. Global Peripheral Artery Disease Market, By Type
5. Peripheral Artery Disease Market, By Region
6. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/td3ftr/global_peripheral?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005542/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH CARDIOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/06/2018 05:44 AM/DISC: 06/06/2018 05:44 AM